Journal articleCancer Lett2013

Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells.

DOI 10.1016/j.canlet.2013.01.007 ↗ OpenAlex, retrieved 5 November 2026

Journal: Cancer Lett
Published: 20 January 2013
Citations: 23
Type: Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try